Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?

• Justin B. Wenger,
• Napoleon Santos,
• Yanxia Liu,
• Jennifer Dallas,
• Sukanthini Subbiah,
• Steven Hochwald,
• Emina H. Huang,
• Long H. Dang,
• Carmen J. Allegra,
• Hendrik Luesch,
• Duyen T. Dang

Affiliations

Justin B. Wenger

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Napoleon Santos

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Yanxia Liu

Department of Medicinal Chemistry, University of Florida

Jennifer Dallas

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Sukanthini Subbiah

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Steven Hochwald

Department of Surgery, University of Florida

Emina H. Huang

Department of Surgery, University of Florida

Long H. Dang

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Carmen J. Allegra

Division of Hematology/Oncology, Department of Internal Medicine, University of Florida Shands Cancer Center, University of Florida

Hendrik Luesch

Department of Medicinal Chemistry, University of Florida

Duyen T. Dang

Department of Internal Medicine, University of Michigan